These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 8651351)

  • 41. Comparative genomic hybridization on microarray (a-CGH) in olfactory neuroblastoma: Analysis of ten cases and review of the literature.
    Valli R; De Bernardi F; Frattini A; Volpi L; Bignami M; Facchetti F; Pasquali F; Castelnuovo P; Maserati E
    Genes Chromosomes Cancer; 2015 Dec; 54(12):771-5. PubMed ID: 26355525
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treatment modalities and outcomes of olfactory neuroblastoma.
    Song CM; Won TB; Lee CH; Kim DY; Rhee CS
    Laryngoscope; 2012 Nov; 122(11):2389-95. PubMed ID: 23070733
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The cytologic features of sinonasal undifferentiated carcinoma and olfactory neuroblastoma.
    Bellizzi AM; Bourne TD; Mills SE; Stelow EB
    Am J Clin Pathol; 2008 Mar; 129(3):367-76. PubMed ID: 18285258
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Olfactory neuroblastoma: a review and update.
    Faragalla H; Weinreb I
    Adv Anat Pathol; 2009 Sep; 16(5):322-31. PubMed ID: 19700942
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clincopathological analysis of olfactory neuroblastoma.
    Fukushima S; Sugita Y; Niino D; Mihashi H; Ohshima K
    Brain Tumor Pathol; 2012 Oct; 29(4):207-15. PubMed ID: 22331316
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comprehensive Genomic Profiling of Esthesioneuroblastoma Reveals Additional Treatment Options.
    Gay LM; Kim S; Fedorchak K; Kundranda M; Odia Y; Nangia C; Battiste J; Colon-Otero G; Powell S; Russell J; Elvin JA; Vergilio JA; Suh J; Ali SM; Stephens PJ; Miller VA; Ross JS
    Oncologist; 2017 Jul; 22(7):834-842. PubMed ID: 28495808
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Initiation of human astrocytoma by clonal evolution of cells with progressive loss of p53 functions in a patient with a 283H TP53 germ-line mutation: evidence for a precursor lesion.
    Fulci G; Ishii N; Maurici D; Gernert KM; Hainaut P; Kaur B; Van Meir EG
    Cancer Res; 2002 May; 62(10):2897-905. PubMed ID: 12019170
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Array comparative genomic hybridization analysis of olfactory neuroblastoma.
    Guled M; Myllykangas S; Frierson HF; Mills SE; Knuutila S; Stelow EB
    Mod Pathol; 2008 Jun; 21(6):770-8. PubMed ID: 18408657
    [TBL] [Abstract][Full Text] [Related]  

  • 49. SSTR2 Expression in Olfactory Neuroblastoma: Clinical and Therapeutic Implications.
    Cracolici V; Wang EW; Gardner PA; Snyderman C; Gargano SM; Chiosea S; Singhi AD; Seethala RR
    Head Neck Pathol; 2021 Dec; 15(4):1185-1191. PubMed ID: 33929681
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53, waf1, pRb and Ki67.
    Tut VM; Braithwaite KL; Angus B; Neal DE; Lunec J; Mellon JK
    Br J Cancer; 2001 Jan; 84(2):270-5. PubMed ID: 11161387
    [TBL] [Abstract][Full Text] [Related]  

  • 51. p53 protein accumulation and gene mutation in the progression of human prostate carcinoma.
    Navone NM; Troncoso P; Pisters LL; Goodrow TL; Palmer JL; Nichols WW; von Eschenbach AC; Conti CJ
    J Natl Cancer Inst; 1993 Oct; 85(20):1657-69. PubMed ID: 7692074
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fine needle aspiration cytology of metastatic olfactory neuroblastoma.
    Collins BT; Cramer HM; Hearn SA
    Acta Cytol; 1997; 41(3):802-10. PubMed ID: 9167705
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cystic Intracranial Recurrence of Olfactory Neuroblastoma without Accumulation on Fluorine-18-fluorodeoxyglucose Positron Emission Tomography.
    Ishi Y; Yamaguchi S; Hatanaka KC; Takakuwa E; Motegi H; Honda T; Kobayashi H; Terasaka S; Homma A; Fujimura M; Houkin K
    Acta Med Okayama; 2022 Feb; 76(1):93-98. PubMed ID: 35237005
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Olfactory neuroblastoma behavior inside and outside the olfactory cleft.
    Jankowski R; Russel A; Gallet P; Henrot P; Vignaud JM; Nguyen DT
    Surg Radiol Anat; 2015 Jul; 37(5):507-15. PubMed ID: 25218517
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Molecular Evidence for Olfactory Neuroblastoma as a Tumor of Malignant Globose Basal Cells.
    Zunitch MJ; Fisch AS; Lin B; Barrios-Camacho CM; Faquin WC; Tachie-Baffour Y; Louie JD; Jang W; Curry WT; Gray ST; Lin DT; Schwob JE; Holbrook EH
    Mod Pathol; 2023 May; 36(5):100122. PubMed ID: 36841178
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A Case of Olfactory Neuroblastoma Developing Bilateral Retropharyngeal Lymph Node Metastasis 14-years After Skull Base Surgery.
    Mizumoto M; Furukawa T; Yui M; Iritani K; Tatehara S; Inokuchi G; Teshima M; Shinomiya H; Kimura H; Kiyota N; Sasaki R; Nibu KI
    Kobe J Med Sci; 2024 Jun; 70(2):E56-E60. PubMed ID: 38936878
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Olfactory neuroblastoma with focal ganglioneuroblastic differentiation: a case report with literature review.
    Squillaci S
    Pathologica; 2014 Jun; 106(2):61-6. PubMed ID: 25291869
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparative evaluation of the expression of cell cycle regulating proteins: cyclin D1, P53 and P21 (WAF1) in colorectal cancer.
    Pasz-Walczak G; Kordek R
    Pol J Pathol; 2000; 51(2):63-9. PubMed ID: 10974928
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evidence of gene deletion of p21 (WAF1/CIP1), a cyclin-dependent protein kinase inhibitor, in thyroid carcinomas.
    Shi Y; Zou M; Farid NR; al-Sedairy ST
    Br J Cancer; 1996 Nov; 74(9):1336-41. PubMed ID: 8912526
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reduced messenger RNA expression level of p21 CIP1 in human colorectal carcinoma tissues and its association with p53 gene mutation.
    Matsushita K; Kobayashi S; Kato M; Itoh Y; Okuyama K; Sakiyama S; Isono K
    Int J Cancer; 1996 Aug; 69(4):259-64. PubMed ID: 8797864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.